Literature DB >> 6847919

Therapy of secondary acute nonlymphocytic leukemia with cytarabine.

H D Preisler, A P Early, A Raza, G Vlahides, M J Marinello, A M Stein, G Browman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6847919     DOI： 10.1056/NEJM198301063080105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Non-cardiogenic pulmonary edema complicating intermediate and high-dose Ara C treatment for relapsed acute leukemia.

Authors:  U Jehn; N Göldel; R Rienmüller; W Wilmanns
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

2.  Comparison of autoradiography and DNA histograms in assessing S-phase cells from patients with myeloid leukemias.

Authors:  A Raza; A S Raza; K Kuliczkowski; S C Zhao; H D Preisler
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  Treatment of therapy-induced preleukemic syndrome.

Authors:  M Gyger; C Perreault; J Carnot; J Boileau; Y Bonny
Journal:  Blut       Date:  1984-02

4.  Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside.

Authors:  H D Preisler; A Raza; M Barcos
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

5.  Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications.

Authors:  C K Williams; J Cuttner; T Ohnuma; E P Ambinder; P P Ferreira; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

6.  Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU.

Authors:  K V Shepard; R Larson; M M Le Beau; L Leichman; B Levin
Journal:  Invest New Drugs       Date:  1988-06       Impact factor: 3.850
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.